HTG Molecular

HTG Transcriptome
Panel Available Now

Simplify gene expression analysis with our new comprehensive human transcriptome panel.

Learn More
VERI/O Laboratory Services

It's not business, it's personal.
We treat our partners like colleagues and your study like our own.

Learn More
HTG EdgeSeq Panels

The most fragile RNA samples can now reveal the greatest insights for gene expression and biomarker discovery.

Learn More
HTG EdgeSeq Systems

Devlivering extraction-free RNA molecular profiling solutions and semi-automated library prep.

Learn More

Harness the Power of HTG's Proprietary Transcriptome Panel

Building on more than a decade of pioneering innovation and partnerships with biopharma leaders and major academic institutes, HTG's RNA platform technologies make the development of life science tools and diagnostics more effective and cost-efficient, enabling researchers to interrogate the entire transcriptome with smaller sample requirements and higher success rates.

Featured Publication

Overview of the Design and Performance of the HTG Transcriptome Panel

This White Paper summarizes the data generated using the HTG Transcriptome Panel from Feasibility through Verification, including comparison to RNA-Seq.

READ PUBLICATION

HTG Molecular News & Events

AACR Annual Meeting 2023

April 14-19, 2023 | Join us at the AACR Annual Meeting in Orlando, FL

Category:
Future Events

Posted on: 03-14-2023

Keep Reading

HTG Provides a Year-End Update on its Drug Discovery Business and Attends LifeSci Partners 2023 Corporate Access Event

TUCSON, Ariz. , Jan. 09, 2023 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling and advanced medicinal chemistry technology, today provided an update on the progress of…

Category:
Press Releases

Keep Reading

HTG Announces Certain Preliminary 2022 Unaudited Financial Results

Preliminary full year 2022 unaudited revenue of $6.4 million Cash and cash equivalents of $12.2 million as of December 31, 2022 TUCSON, Ariz. , Jan. 06, 2023 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its…

Category:
Press Releases

Keep Reading

HTG Molecular Diagnostics Provides Highlights of its Second Event in Drug Discovery KOL Webcast Series

TUCSON, Ariz. , Dec. 28, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling and advanced medicinal chemistry technology, provides here a summary of its second HTG…